Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Alerje
AddedFeb 16, 2024
UpdatedJun 18, 2026
Alerje

Alerje

Seed

Alerje: A digital health startup improving life for food allergy sufferers with an innovative management platform & app.

HQ
Detroit, MI, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Alerje, founded with the mission to improve the quality of life for individuals affected by food allergies, offers a comprehensive digital health platform. The company’s core products include an app that allows users to create and share food allergy profiles, filter recipes, and scan grocery items for allergens. Additionally, Alerje has developed an innovative epinephrine auto-injector integrated into a smartphone case, enhancing patient adherence and providing timely alerts. Their market focus is on the over 220 million people worldwide who suffer from food allergies.

Notable affiliated individuals and investors include experts in digital health and emergency medicine, although specific names are not disclosed. Key achievements of Alerje include the successful development and deployment of their integrated epinephrine auto-injector and app, which have significantly impacted the daily management of food allergies. The overall impact of Alerje is seen in its ability to provide practical tools that empower users to take control of their food allergies, thereby improving their quality of life.

Alerje - Similar Companies

Allergenis logo

Allergenis

allergenis.com

Allergy Amulet logo

Allergy Amulet

allergyamulet.com

Allermi logo

Allermi

Arrow Allergy logo

Arrow Allergy

arrowallergy.com

AllerPops logo

AllerPops

allerpops.com

Ayble Health logo

Ayble Health

ayblehealth.com

alvee logo

alvee

alvee.io

ARS Pharmaceuticals logo

ARS Pharmaceuticals

ars-pharma.com

Allergood logo

Allergood

EpiWatch logo

EpiWatch

epiwatch.com

AllergEase logo

AllergEase

AdrenaCard logo

AdrenaCard

adrenacard.com

Sniffle Health logo

Sniffle Health

sniffle.com

Nectar Life Sciences logo

Nectar Life Sciences

Aleriom logo

Aleriom

aleriom.com

Alerje - Quick Facts

Who are Alerje's competitors?

Companies similar to Alerje include Allergenis, Allergy Amulet, Allermi and Arrow Allergy.

When was Alerje founded?

Alerje was founded in 2016.

Where is Alerje's headquarters located?

Alerje's headquarters is located in Detroit, MI, US.

How much has Alerje raised to-date?

As of Jan 23, 2024, Alerje has raised a total of $3.1M (USD).

How many employees does Alerje have?

Alerje has 7 employees as of Feb 5, 2024.

Alerje - Classification

Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Digital Health
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified